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Protein dynamics are often invoked in explanations of enzyme catalysis, but their design has
proven elusive. Here we track the role of dynamics in evolution, starting from the evolvable
and thermostable ancestral protein AncHLD-RLuc which catalyses both dehalogenase and
luciferase reactions. Insertion-deletion (InDel) backbone mutagenesis of AncHLD-RLuc chal-
lenged the scaffold dynamics. Screening for both activities reveals InDel mutations localized
in three distinct regions that lead to altered protein dynamics (based on crystallographic B-
factors, hydrogen exchange, and molecular dynamics simulations). An anisotropic network
model highlights the importance of the conformational flexibility of a loop-helix fragment of
Renilla luciferases for ligand binding. Transplantation of this dynamic fragment leads to lower
product inhibition and highly stable glow-type bioluminescence. The success of our approach
suggests that a strategy comprising (i) constructing a stable and evolvable template, (ii)
mapping functional regions by backbone mutagenesis, and (iii) transplantation of dynamic
features, can lead to functionally innovative proteins.
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Contemporary biocatalysts may originate from a smallnumber of possibly multifunctional common ancestorsand a limited number of structural folds. Natural enzymes
have undergone billions of years of evolution to generate vast
functional diversity and strikingly precise and efficient activities.
This diversity resulted from complex evolutionary processes1,
which have been grouped into two complementary mechanisms:
creeping and leaping evolution2. The former involves relatively
minor functional changes that generally increase specificity or
activity, whereas the latter involves radical shifts that introduce
functional innovations such as the ability to bind a completely
different substrate or change an enzyme’s mechanism. While
small adaptive changes may result from point substitutions
introduced during evolution3, larger functional leaps may require
more profound rearrangements of the protein backbone4. How-
ever, the potential for innovation comes at the price of disruption
and destabilization. One way to harvest the effects of profound
modifications is to infer ancestral enzymes5 with features that
enhance evolvability: stability and promiscuity6,7. This enables
the creation of robust generalist scaffolds that may be more cat-
alytically versatile because they are less burdened by adaptive
pressure towards a specific function than their modern-day
counterparts8,9. If ancestors are indeed more stable, their capacity
to buffer the large mutational load arising from backbone
modifications4 may be enhanced.
Most directed evolution efforts rely on point substitutions.
There have been far fewer reports of experimental insertions or
deletions (InDels), despite their relatively frequent and beneficial
occurrence in natural evolution10. Various genomic analyses
show that the ratio of InDels to point substitutions in protein-
coding regions typically ranges from 1:5 in primates to 1:20 in
bacteria, indicating that InDels are typically subjected to stronger
purifying selection than substitutions during evolution. This is
due to their potentially more deleterious effects, including losses
of stability, disruptions of secondary structure elements and/or
perturbations of folding pathways11. To explore the potential
effects of InDel mutagenesis on functional proteins, we previously
developed TRIAD (transposition-based random insertions and
deletions)12,13, a method for generating random InDel libraries
that provides ready access to variants that cannot be obtained
by substitution mutagenesis https://doi.org/10.21203/rs.3.pex-
1448/v1. TRIAD is transposon-based and was shown to have
only minimal sequence bias, with >85% of all possible sites shown
to be targeted by the transposon12. In the present work, TRIAD is
applied to a particularly stable ancestral protein14, the recently
designed and characterized AncHLD-RLuc that was reconstructed
from the catalytically distinct but evolutionarily and structurally
related haloalkane dehalogenases15 (HLD, EC 3.8.1.5) and Renilla
luciferase16 (RLuc, EC 1.13.12.5). This ancestor14 is bifunctional
and catalytically versatile, with a dehalogenase activity comparable
to contemporary HLDs and a promiscuous luciferase activity
almost 7000-fold lower than that of the stabilized RLuc8, a pop-
ular molecular probe. The light-producing reaction catalysed by
the Renilla-type luciferase is one of the most widely used bio-
chemical reactions in molecular and cell biology research. Based
on conformational differences of the RLuc8 backbone in crystal
structures17, it had been suggested that the opening of the L9 loop
might be relevant for luciferase substrate binding. The availability
of AncHLD-RLuc, a stable bi-functional scaffold14, enabled inves-
tigation of structure-function relationships of luciferase activity.
Here we present a three-step protein engineering strategy
designed to exploit the effects of InDels as promotors of evolu-
tionary innovation: (i) constructing a robust and evolvable tem-
plate, (ii) mapping functional regions by backbone mutagenesis
and multivariate statistics and (iii) transplantation of a dynamic
structural (loop-helix) feature. Its application to the bifunctional
protein AncHLD-RLuc (Fig. 1) results in an engineered 7000-fold
more efficient catalyst with 100-fold longer glow-type biolumi-
nescence applicable as a molecular probe for use in bacterial as
well as mammalian cells.
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Fig. 1 Illustration of the strategy for semi-rational engineering of protein
dynamics. Exploratory phase—1 A thermostable ancestral protein, AncHLD-
RLuc, provided a robust and evolvable template that can withstand the
destabilizing effects of protein backbone engineering. 2 Libraries of single
triplet insertion and deletion variants were created following the TRIAD
method based on the use of engineered transposons (TransIns and
TransDel)12,13. 3 Screening of the libraries led to identification of the
improved insertion mutant AncINS. 4 Twenty-five mutants with significant
changes in luciferase (LUC) and haloalkane dehalogenase (HLD) activities
were characterized using bioinformatics, microscale techniques (nano
differential scanning fluorimetry—nanoDSF), and microfluidics. 5 Structure-
function relationships were described employing partial least squares (PLS)
multivariate statistics. 6 Dynamic elements required for efficient catalysis
were identified by structural, kinetic, biophysical and computational
characterization (molecular dynamics (MD) simulations) of AncINS.
Validation phase—7 Knowledge obtained during the exploratory phase was
validated by transplanting a relevant dynamic fragment from the specialized
descendant into the ancestor, yielding an enzyme, AncFT, with 7000-fold
higher catalytic efficiency than AncHLD-RLuc and 100-fold longer glow-type
bioluminescence than the flash-type Renilla luciferase RLuc8. Key mutants
discussed in this study are highlighted in yellow.
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Results
Structure–function relationships by analysis of InDel libraries.
Libraries of AncHLD-RLuc with random single amino acid inser-
tions (1st round, R1I) and deletions (1st round, R1D) distributed
over the length of the protein were constructed using TRIAD12
and screened for LUC and HLD activities (Supplementary Note
1). All hits with significantly improved LUC activity had back-
bone alterations localized in one of three regions of the enzyme
cap domain: the L9 loop, the α4 helix or the L14 loop (Fig. 2a,
Supplementary Table 1). We selected 11 variants (10 from R1I, 1
from R1D) for further analysis and complemented them with 15
variants with low LUC activity that retained HLD activity (8 from
R1D and 7 from R1I, Source data file). All variants were
expressed, purified and subjected to activity and stability mea-
surements and thermodynamic analyses using a microfluidic
approach (Supplementary Fig. 1). To understand the role of
cooperativity and long-range interactions after mutagenesis, we
used an anisotropic network model (ANM, Supplementary Note
2) to calculate the cross-correlation of motions of selected
structural fragments (Supplementary Tables 2, 3, Supplementary
Note 3) to the regions carrying the InDel mutations of the
selected variants.
Multivariate partial least squares (PLS) regression (Supplemen-
tary Note 4) revealed that the initiation of protein unfolding (Tonset)
and its midpoint (Tm) were the strongest predictors for both LUC
and HLD activities. At Tonset (0.5% deviation from a linear fit on the
330 nm/350 nm vs. temperature curve) a protein starts to unfold,
while at Tm (inflection point on the 330 nm/350 nm vs. temperature
curve) 50% of the protein is unfolded. The directionality of the
relationships was the opposite for HLD and LUC activities (Fig. 2b).
This suggested that stabilities are linked, positively and negatively,
to the two activities with their distinct chemical mechanisms and
structural requirements. Moreover, cross-correlated motions of the
mutated positions to the L9 loop were identified as very strong
contributors to LUC activity, and cross-correlated motions to the L3
and L18 loops (which encompass catalytic residues14,18) as key
contributors to HLD activity.
All the positive hits had significantly reduced thermal stability
compared to the ancestral protein (up to –20 °C lower Tonset and
Tm values; Source data file), in agreement with the notion that a
stable template is crucial for obtaining functional mutants.
Moreover, we assumed that using a highly stable starting point
for engineering would promote evolvability by allowing the
protein to accept a wider range of mutations while retaining its
native fold19, thereby enabling multiple rounds of directed
evolution. To probe this hypothesis, the best variant from R1I
library (AncINS) carrying an insertion and substitution in the α4
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Fig. 2 Quantitative structure-function relationships and analysis of the effects of template and mutation type on activity. a Crystal structure of the
thermostable AncHLD-RLuc (PDB ID 6G75) showing the positions of the L9 loop (light blue), the α4 helix (salmon) and the L14 loop (pale green), where
InDels (spheres) resulted in an increase of luciferase (LUC) activity. Correlated motions of L3 (marine) and L18 (yellow) loops carrying two of the five
catalytic amino acids (spheres) were identified as significant contributors to dehalogenase (HLD) activity by the partial least squares (PLS) regression
analysis. b Weighted coefficients quantifying contributions of variables indicated in the PLS models to explain the variance in HLD (green) and LUC (blue)
activity. Note that different directionality of these coefficients for all variables, except loop L9, suggests different mechanistic and structural requirements
for the two enzymatic functions studied. PLS generated models that explained substantial amounts of the variation in both LUC activity (R2= 0.73, Q2=
0.67, n= 25 is the number of InDel variants) and HLD activity (R2= 0.63, Q2= 0.54, n= 25 is the number of InDel variants). To obtain Q2 the model was
recalculated 999 times with a randomly re-ordered dependent variables. c Comparison of frequencies of variants with their activities relative to the
ancestral protein in the first-round insertion (R1I, blue) and deletion (R1D, red) libraries. The template for R1I and R1D was AncHLD-RLuc. The best insertion
variant AncINS is indicated by an arrow. d Comparison of frequencies of variants with indicated activities relative to their respective templates observed in
the first round of insertion library (R1I, blue) and the second round of insertion library (R2I, yellow). Note that the starting template AncHLD-RLuc for R1I and
R1D is less active than the starting template AncINS for R2I. The template for R2I was AncINS. Source data is available as a Source data file for Fig. 2.
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acid insertion library (2nd round, R2I) that was screened for
further improvement in LUC activity. Statistical analysis of
activity data shows that R1I and R1D yielded populations of
variants with similar LUC activity patterns, and most of the
increases in relative activity obtained in these rounds were
compromised in R2I (Fig. 2c, d). The proportions of variants
showing at least doubled activity of the starting template
generated in R1I, R1D and R2I were 13%, 15.5% and just 0.5%,
respectively. As no significant activity improvements were
obtained in the second round of insertion mutagenesis, no
further rounds were pursued.
The finding that a single round of InDel mutagenesis of the
stabilized template already provided mutants with >100-fold
increases in LUC activity raises the question: why are the
structural elements (L9 and L14 loops and α4 helix), highlighted
by directed evolution experiments, crucial for LUC activity? To
address this question, the mutant AncINS, carrying an insertion
in the α4 helix, was selected as a representative and studied by
transient and steady-state kinetics.
Kinetic analysis underlines the importance of conformational
flexibility for substrate binding. To gain insight into the cata-
lytic mechanism, steady-state kinetics of LUC activity of the three
luciferases (AncINS, the template AncHLD-RLuc and the modern
variant RLuc8; Fig. 1). were measured with the substrate coe-
lenterazine (CTZ). Complete luminescence progress curves
(Supplementary Fig. 5) gave, by numerical simulation, estimates
of the turnover number (kcat) and the enzyme specificity constant
(kcat/Km). kcat provides a lower limit for each first-order rate
constant following binding of a substrate through product release,
while kcat/Km indicates a lower limit of the rate for substrate
binding (Fig. 3a). The parameters obtained for RLuc8 correspond
well with previously reported values derived from initial rate
measurements combined with quantum yield calibration (Sup-
plementary Table 4)20. Moreover, following a time course of the
substrate-to-product conversion, our data provide a sensitive
estimate of the equilibrium dissociation constants for each
enzyme–product complex (Kp) that cannot be obtained by con-
ventional initial rate analysis. Both kcat and kcat/Km values of
AncINS were in-between those of AncHLD-RLuc and RLuc8,
indicating a 124-fold enhancement of its catalytic efficiency
relative to that of the ancestral enzyme.
We also investigated by pre-steady-state kinetic analysis,
whether conformational changes of the protein are essential for
effective binding of the bulky CTZ substrate (Fig. 3b). The
combination of analytical data processing and global fitting by
numerical integration revealed a two-step induced fit substrate-
binding mechanism: initial collision of the enzyme with the
substrate, followed by an induced conformational change of the
enzyme (Fig. 3b, Supplementary Fig. 6). Details and the rationale
of the mechanistic analysis are described in the Supplementary
Information (Supplementary Note 5). The kinetic constants are
consistent with a model in which the reaction catalysed by
AncHLD-RLuc involves a slow simple binding mechanism, with no
sign of conformational flexibility. By contrast, we detected
conformational flexibility of AncINS, accompanied by 1000-fold
Fig. 3 Steady-state and transient kinetic analysis of CTZ conversion. The kinetic models consist of an enzyme E, a substrate S, an enzyme-substrate
complex in two conformations (E.S and E*.S), an enzyme-product complex E.P, and a product P. a Steady-state kinetic parameters (Michaelis constant Km,
turnover number kcat, enzyme-product complex dissociation constant Kp) were determined with the substrate CTZ in 100mM phosphate buffer at pH 7.5
and 37 °C by global analysis of triplicates of full progress curves recorded with at least five concentrations of CTZ. b Results of pre-steady-state kinetic
analysis of the CTZ substrate binding in 100mM phosphate buffer at pH 7.5 and a lower temperature (15 °C). This enabled identification of the induced fit
substrate binding mechanism, involving initial collision of the enzyme and the substrate (described by forward rate constant k+1 and reverse rate constant
k−1), followed by a conformational change of the enzyme induced by the bound substrate (described by forward rate constant k+2 and reverse rate
constant k−2). A simple binding mechanism including only the first step was observed for AncHLD-RLuc. The kinetic parameters were determined by global
fitting of tryptophan fluorescence traces obtained with at least 10 concentrations of CTZ and 10 concentrations of each tested enzyme, in each case with
seven replicates (Supplementary Note 6). The data are presented as best fit values ± standard errors (S.E.) calculated from the covariance matrix during
nonlinear regression. Source data is available as a Source data file for Fig. 3.
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faster binding, based on determined k+1 and k-1. The changes in
AncINS increased rates of the initial collision step to match those
of RLuc8, but a subsequent conformational change was still 10-
fold slower. Faster kinetics of substrate binding after backbone
modification in the α4 helix suggest that this region plays a
significant role in the initial step of the catalytic cycle.
Backbone conformational differences in crystal structures. To
investigate the relationship between the structural changes
induced in AncHLD-RLuc by InDel mutagenesis and enhanced
kinetics of substrate binding, we crystallized AncINS (PDB ID
6S6E, Supplementary Table 6) and compared its structure to
previously published structures of AncHLD-RLuc (PDB ID 6G75)
and RLuc8 (PDB ID 2PSF). These proteins have identical α/β-
hydrolase folds but differ in their cap domains. Important
changes were identified in the conformation of the α4 helix and
L9 loop in the cap domain, size of the active site cavity, width of
the tunnel mouth, and active site accessibility (Fig. 4).
The asymmetric unit of the crystal lattice of AncINS contains
two monomers (chains A and B). Chain A has a structure similar
to the AncHLD-RLuc template but features a π-helix bulge in the α4
helix where the L162 insertion and F163P substitution occurred.
In AncINS chain B, the α4 helix is markedly distorted towards the
α5 helix. Moreover, the electron density map for the L9-α4
fragment is not perfectly resolved. Some side chains are poorly
visible or invisible, suggesting that appreciable internal motion
occurs in this region. RLuc8 also has two monomers in the
asymmetric unit; chain B is similar to that of AncHLD-RLuc, while
chain A is in an open conformation with the α4 helix pointing
away from the α5 helix.
In AncINS, the inserted L162 occupies the same position as the
bulky F162 in AncHLD-RLuc, making the active site cavity of
AncINS bigger than that of AncHLD-RLuc. The F163P substitution
in AncINS disrupts the α4 helix because proline acts as a helix
breaker, introducing a kink into the polypeptide backbone. The
resulting distortion closes the main access tunnel in the chain B of
AncINS. In RLuc8, the situation is a little bit more complex. The
sequence alignment (Supplementary Fig. 9) indicates that I163 is
a conserved amino acid, but it does not occupy the same position
as I161 in AncHLD-RLuc. Instead, it is flipped down into the
position occupied by the bulky F162 in AncHLD-RLuc. The
outward conformation of the α4 helix in the cap domain of RLuc8
chain A gives it the largest active site cavity of the crystal
structures studied.
To ascertain the role of the L9-α4 fragment in substrate
binding, we tried to co-crystallize RLuc8 with CTZ. Despite our
best efforts, we did not obtain sufficiently well diffracting crystals.
In contrast, mixing the RLuc8-W121F/E144Q mutant with CTZ
yielded a high-resolution complex structure (Fig. 5a; Supplemen-
tary Table 6) with coelenteramide (CEI), which is the product of
the LUC reaction. Unlike in an RLuc8-CEI complex structure17,
the CEI molecule in our complex is inverted by nearly 180°,
which allows its accommodation in the luciferase active site cavity
(Fig. 5b, Supplementary Fig. 10). The rest of the CEI molecule
occupies the main enzyme access tunnel, where it is tightly
wrapped by multiple, predominantly hydrophobic, residues:
V146, I150, I159, V185, F181, F261, F262, H285 and I266.
Interestingly, many of the residues directly interacting with the
CEI are located on the loop L9 (V146, I150, W156 and I159) and
the loop L14 (I223 and P224), identified as important for catalysis
by our directed evolution experiments. The α4 helix is in an open
conformation relative to the α5 helix (Fig. 5c). Ultimately, the L9-
α4 fragment directly affects the opening and closing of the access
tunnels and we deduce that it is involved in substrate binding and
product release. Thus, our structural data support conclusions
from InDel mutagenesis and kinetic studies that the L9-α4
fragment is the key hotspot region for the introduction of LUC
activity.
Profiling protein dynamics by mass spectrometry and mole-
cular dynamics. To analyse the effects of dynamics on LUC
activity, we recorded hydrogen-deuterium exchange mass spec-
trometry (HDX-MS) time courses and complementary molecular
dynamics (MD) simulations (Fig. 6). In this context, it should be
emphasized that HDX-MS reveals changes occurring over sec-
onds or minutes, whereas MD simulations cover a few micro-
seconds (in this case 4.8 μs). Kinetic analyses were carried out
with the substrate, while HDX-MS and MD simulations were
performed in the absence of any ligand. HDX-MS captures both
dynamics and solvation.
Backbone amide hydrogen-deuterium exchange is particularly
sensitive to hydrogen bonding and thus reflects hydrogen
bonding strength, conformational dynamics, and the solvent
accessibility of protein structures. The HDX-MS profiles (Fig. 6c,
Supplementary Fig. 11) show that AncINS was deuterated more
rapidly overall than the template AncHLD-RLuc, and that the
modification of its α4 helix backbone leads to greater solvation
and more pronounced dynamics, particularly in the cap domain
region (Supplementary Fig. 11). Moreover, AncINS exhibited very
high overall deuteration within 10 and 60 s, with the amino acids
between residues W151 (L9 loop) and F180 (α5 helix) of the cap
domain being most extensively deuterated. Residues S212-E235
(which comprise the L14 loop) were also appreciably more
deuterated than their counterparts in AncHLD-RLuc. The deutera-
tion of the α4-α5 fragment in RLuc8 reached a deuteration level
comparable to the level observed in AncINS within 60 s, but it
increased further in 300 s. In addition, the L9 loop of RLuc8 was
less extensively deuterated than the corresponding loop in
AncHLD-RLuc and the region S212-E235 (L14 loop) of RLuc8
was more heavily deuterated than in AncHLD-RLuc. These
deuteration patterns in HDX-MS indicate a possible correlation
between the dynamics of hot spot regions comprising the α4 and
α5′ helices and L14 loop and high LUC activity. The protein
dynamics are coupled to efficient binding of the bulky substrate
and release of the structurally similar product, based on the
kinetic constants k+1 and k-1 obtained by the pre-steady state
kinetics (Fig. 3b, Supplementary Fig. 6).
The regions encompassing the L9-α4 fragment and L14 loop
are important structural elements that line the main access
tunnels connecting the buried active site to the surrounding
solvent. Their motions are concerted based on ANM and
significantly affect the active site’s volume, while fully preserving
the catalytic residues’ geometry. Since HDX-MS experiments
measure the exchange of backbone amide hydrogens with
deuterium, we used backbone B-factors from MD simulations
to characterize the enzymes’ dynamics14,21. The overall B-factors
obtained for the cap domain of RLuc8 were highest in the α4
helix, followed by the α5′ helix and L9 loop (Fig. 6b). The B-
factors for the L14 loop were similar to those of the L9 loop, but
values for the rest of the cap domain were below average
(Supplementary Fig. 12). The dynamic profile of the AncHLD-RLuc
template differs significantly: unlike in RLuc8, the dynamics are
most pronounced in the L9 loop. Interestingly, the AncINS
mutant exhibits markedly higher B-factors in the α4 helix,
making it the most dynamic region together with the L9 loop
(Fig. 6b).
Validation by fragment transplantation yields stable glow-type
bioluminescence. To verify the importance of the hotspot regions
highlighted by biophysical analysis, we transplanted the sequence
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Fig. 4 Comparison of structural changes in the apo forms of the enzymes. AncHLD-RLuc (white), AncINS (chain A light blue, chain B slate), AncFT
(salmon), RLuc8 (chain A pale cyan, chain B light teal). a Top view of the active site. The putative catalytic pentad and α5 helix occupy the same position in
all proteins, but the α4 helix adopts different conformations. b Crystal structure of the whole protein, with the main access tunnel (identified using Caver
3.0223) shown as spheres. The outward/inward movement of the α4 helix causes opening/closing of the tunnel. c Front view of the main tunnel. The black
arrow indicates the visible constriction due to closure of the α4 helix. d The size of the active site cavity is changed by repositioning of amino acids in the
α4 helix. e The size of the main tunnel mouth is changed by movements of the α4 helix and L9 loop.
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corresponding to the L9-α4 fragment from the modern RLuc8
enzyme into the ancestral AncHLD-RLuc. The resulting AncFT
protein had lower thermal stability than the ancestral variant
(with ca. 7 °C lower Tm value) but folded correctly (with a CD
spectrum similar to that of AncHLD-RLuc and AncINS; Supple-
mentary Fig. 13). We also constructed a second variant with L14
transplanted from RLuc8 onto the ancestral scaffold, but this
protein easily aggregated, preventing its biochemical
characterization.
Transplantation of the L9-α4 flexible region from RLuc8 into
the scaffold of AncHLD-RLuc affected substrate-binding kinetics
(Fig. 3): AncFT was found to have comparable initial collision
kinetics to AncINS and RLuc8, but the fragment transplantation
enhanced the following conformational change and (unlike
AncINS) AncFT reached the overall binding efficiency of the
modern luciferase. These findings correspond well with the
results of the steady-state analysis. Similar values of the specificity
constant kcat/Km were obtained for AncFT and RLuc8, indicating
comparable efficiency of substrate binding. Thus, AncFT’s lower
LUC activity is due to a lower rate of the chemical transformation
(i.e., the step after binding), as indicated by a 10-fold lower kcat
value for AncFT compared to RLuc8 (Fig. 3a, Supplementary
Table 4). On the other hand, AncFT exhibited markedly weaker
product inhibition than RLuc8. This was apparent from a
significantly lower Km/Kp ratio, quantifying a binding of the
substrate and the product, which has an important effect on the
bioluminescence signal’s stability. The significant product inhibi-
tion of RLuc8, indicated by the high Km/Kp, is one of the reasons
why the bioluminescence signal provided by the luciferase rapidly
decays after a strong initial flash. The fast inactivation and signal
instability are major limitations of this popular molecular probe.
Re-engineering of RLuc8 by ancestral reconstruction and
subsequent backbone modification changed the unstable flash-
type of bioluminescence to a significantly more stable glow-type
bioluminescence. The half-life (t1/2) of AncFT bioluminescence
was two orders of magnitude longer than that of RLuc8
(Supplementary Table 7, Fig. 7a, Supplementary Fig. 14), being
consistent with a significantly lower Km/Kp ratio determined for
AncFT, in comparison to RLuc8. The highly stable glow-type
bioluminescence of AncFT persisted when this protein was
expressed heterologously in mammalian (mouse fibroblast) cells
(Fig. 7b, Supplementary Fig. 14). This result indicates that AncFT
could be used as a reporter protein22 for in vivo experiments.
Crystallographic analysis of AncFT (PDB ID 6S97, Supple-
mentary Table 6) revealed a canonical α/β-hydrolase fold similar
to that of AncHLD-RLuc, but with some structural features
reminiscent of RLuc8. Most importantly, both the active site
cavity and the α4 helix conformation of AncFT are more open
than in AncHLD-RLuc, AncINS, and even the RLuc8 chain B
(Fig. 4). Chain A of RLuc8 (PDB ID 2PSF) has the most open
conformation seen in any of the structures (Figs. 4, 6a).
HDX-MS experiments showed that the deuteration pattern of
AncFT was almost identical to that of AncHLD-RLuc, with
differences only in the transplanted region (Fig. 6c, Supplemen-
tary Fig. 11). Specifically, the end of the L9 loop was less
extensively deuterated than in AncHLD-RLuc while the α4-α5′
helices were more heavily deuterated. A similar trend was
observed for RLuc8, providing experimental evidence that cap
domain dynamics of the mutant with the transplanted fragment
mimic those of RLuc8 (Fig. 6c).
MD simulations of AncFT revealed that the B-factor profile of
its cap domain closely resembled that of RLuc8 (Fig. 6b). The B-
factors were highest in the α5′ and α4 helices, while those of the
L9 and L14 loops were close to the average for the rest of the
enzyme and the rest of the cap domain had lower values
(Supplementary Fig. 12). Tunnel analysis using Caver23 showed
that tunnel dynamics of AncHLD-RLuc and AncINS clearly differ
from those in AncFT and RLuc8 (Fig. 6d). The former two
enzymes can adopt conformations with closed tunnels (average
bottleneck radii: 0.9 and 1.0 Å, respectively), and conformations
with open tunnels (average bottleneck radii: 1.7 Å in both cases).
We consider a tunnel to be closed when its bottleneck radius
drops below the radius of a water molecule (1.4 Å). In contrast,
there is a clear overlap in bottleneck values calculated for the
extremes of the conformational spectra of AncFT and RLuc8: the
conformations that form the narrowest tunnels have identical
Fig. 5 Structural characterization of coelenteramide binding to the catalytically defective RLuc8-W121F/E144Q mutant. a Cartoon representation of the
overall structure of the RLuc8-W121F/E144Q mutant with coelenteramide (CEI) in its active site. CEI is the product of the LUC reaction and shown as cyan
space-filling spheres. Residues of the conserved catalytic pentad are shown as purple spheres; the central eight-stranded β-sheet is coloured yellow; the α4
helix and L9 loop (L9-α4 element) are coloured violet, and the L14 loop is coloured orange. b Cutaway surface representation of the enzyme active site
cavity with the bound CEI (shown as cyan sticks). The colouring is the same as in panel (a). Water molecules are shown as red spheres. c Close-up view of
structural superposition of RLuc8-W121F/E144Q (green), RLuc8 (PDB ID 2PSF A; cyan) and RLuc8 (PDB ID 2PSF B; teal). CEI is shown as cyan space-filling
spheres. Note the conformational sampling of the L9-α4 fragment. The bottom 4-hydroxyphenyl group connected to the CEI acetamide moiety is deeply
buried in the active site cleft, where it is anchored in the slot tunnel through multiple hydrophobic (P224, I223 and I266) and aromatic π-stacking (W156)
interactions. The 4-hydroxyphenyl group interacts with the indole NH group of W156 through a water-mediated hydrogen bond bridge. The acetamide
moiety of CEI is positioned close to the conserved catalytic centre. In chain B, the top 4-hydroxyphenyl group linked with the CEI pyrazine ring interacts
with a side chain of K189 through a water-mediated hydrogen bond bridge and forms a hydrogen bond with the carboxylate group of D162 from a
symmetry-related enzyme molecule.
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average bottleneck radii of 1.5 Å, while those forming open
tunnels have average bottleneck radii of 1.7 and 1.9 Å,
respectively (Fig. 6d).
In addition, we performed an analysis of the cavity size of the
proteins to test whether changes in the catalytic properties
correlate with the changes in the volume of the active site. When
analysing 100 random snapshots from MD simulations we
noticed that cavity volumes of all proteins can adopt wide ranges,
but they also converge to similar minimal volume of 200 Å3 in the
closed state. The volumes calculated from the simulations starting
from the open and closed conformations showed different
absolute values, except for AncFT, which does not have multiple
monomers in the asymmetric unit (Supplementary Fig. 15).
Neither analysis of volumes of the static structures nor 100
representative snapshots obtained from MD simulations show
any sign of correspondence between the catalytic characteristics
and the active site volumes. Furthermore, on interpreting whether
the system dynamics or the cavity volume is more important for
the catalytic activity, the analyses of the ANM presented above
agree with the importance of the dynamics.
Discussion
The present work validates a strategy for engineering enzyme
backbone dynamics based on InDel mutagenesis of a stable (high
melting temperature) and catalytically promiscuous (evolvable)
template. We used TRIAD12 mutagenesis to generate single amino
acid insertion and deletion libraries of a stabilized bi-functional
ancestral enzyme14 of haloalkane dehalogenase and Renilla-type
luciferase enzymes (Fig. 1). Alternatively, other published methods
for introducing insertions and deletions could be used24–27. The
most potent insertion variant, AncINS, has both an insertion and
a substitution in the α4 helix. These mutations markedly improved
substrate binding, linked to changes in dynamics of the cap
domain, but not the putative catalytic pentad. Remarkably, this
was achieved in a single round of mutagenesis. In contrast, rou-
tinely used substitution mutagenesis protocols often require
multiple time-consuming rounds of directed evolution and high-
throughput screenings28–30. Systematic mutagenesis strategies,
that allow a single-round selection to identify regions of interest
for more focused study, are available31. In the future, maximizing
information obtained from the selection through deep sequencing
of gene libraries32 may also provide information to predict ben-
eficial mutations based on a single round.
The crystal structure of the insertion variant AncINS (PDB ID























Fig. 6 Engineering conformational dynamics by backbone modifications. a
Conformational dynamics in the cap domains of crystal structures: AncINS
(PDB ID 6S6E) has two monomers in the asymmetric unit differing in
conformation of the α4 helix carrying the insertion. Chains A (light blue)
and B (slate) are in the open and closed conformations, respectively. RLuc8
(PDB ID 2PSF) has analogous conformations, with an open chain A (pale
cyan) and a closed chain B (light teal). AncFT (PDB ID 6S97) has one
monomer in the asymmetric unit, in which helix α4 is more open than in
AncHLD-RLuc, AncINS, and even RLuc8 chain B. b Conformational dynamics
in the cap domains observed during molecular dynamics simulations. B-
factors of backbone atoms standardized across all protein variants, ranging
from −2 (blue) to 2 (red). B-factor values standardized for each protein are
indicated by the thickness of the lines representing the protein backbone.
Values were averaged per secondary structure element. c Dynamics and
hydration of the cap domain based on HDX-MS assessments of peptide
deuteration after 60 s. AncHLD-RLuc is most heavily deuterated in the L9
loop. The deuteration pattern of AncFT is most similar to that of RLuc8. d
Main access tunnel geometries of the proteins: representative snapshots of
the open (lighter shades, upper row) and closed (darker shades, lower row)
conformations. Average bottleneck radii and standard deviations from n=
1000 snapshots from MD simulations were calculated by Caver 3.0223.
The grey area corresponds to closed conformational states with tunnel radii
below 1.4 Å (the radius of a water molecule). Source data is available as a
Source data file for Fig. 6b and c.
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with different spatial arrangements of the α4 helix (implying they
represent two conformers), and MD simulations confirmed that
the mutations caused substantial structural rearrangements, most
probably because the substituted residue P163 acts as a helix
breaker. We conclude that the LUC activity benefits from con-
formational dynamics of the protein’s rigid scaffold to allow
binding of a bulky substrate. The outward movement of the α4
helix has an immediate effect on the opening of the access tunnel
and increasing of the buried cavity’s volume, thus facilitating
binding of the bulky substrate CTZ. However, once CTZ is bound
inside of the active site cavity, the protein has to provide tight
binding of the molecule inside it and provide a desolvated
environment for the subsequent monooxygenation reaction and
bioluminescence to occur33,34. If the excited product of the
reaction, CEI, would not be tightly bound, the energy would
probably not be released in the form of light during decay to the
ground state, but in another form, e.g., heat. Accordingly, we
propose that the evolutionary processes that generated the
modern Renilla luciferase altered its dynamics in a way that
facilitated substrate binding to the open state. While the move-
ment of the α4 helix was shown to be important for CTZ binding,
the dynamic profile of AncINS, as determined by HDX-MX
experiments and MD simulations, still differs from that of RLuc8.
To validate the proposed conclusions, we transplanted the α4
helix and L9 loop from the highly efficient modern RLuc8 into
the poorly active ancestral AncHLD-RLuc. The resulting enzyme,
AncFT, was highly efficient, with significantly decreased product
inhibition compared to RLuc8, providing glow-type lumines-
cence. Crystallographic analysis revealed that its structure (PDB
ID 6S97) was more open than those of both the ancestral protein
and B chain of RLuc8, facilitating the entrance of the bulky
substrate. Based on MD simulations and HDX-MS experiments,
we conclude that the transplantation reduced motions of the L9
loop, but increased motion of the α4-α5′ helices, making the
mutant protein’s dynamics more similar to RLuc8.
Our results provide experimental evidence for the role of
protein dynamics in enzymatic catalysis. An ancestral protein
(AncHLD-RLuc) with sub-optimal dynamics has its catalytic
activity limited by substrate binding, while mutants with tailored
dynamism resulting from insertion/substitution (AncINS) or
fragment transplantation (AncFT) have catalytic activity limited
by the subsequent step of the chemical reaction. Transplantation
of the most dynamic region of the extant RLuc onto the ancestral
AncHLD-RLuc improved its catalytic efficiency 7000-fold to match
the catalytic efficiency of RLuc, while extending the half-life of its
light output 100-fold. Long-lasting glow-type light emission of
AncFT was confirmed in mammalian cells, which paves the way
towards its use as an efficient molecular reporter or biosensor22.
Given the growing sensitivity of optical devices, signal stability is
becoming a key requirement for modern molecular probes. In
comparison with the short-term flash type of signal, a stable glow
signal enables continuous detection in long-term biological
experiments or maintenance of a stable response required during
high-throughput screening campaigns22.
Thus, both the introduction of InDels and transplantation of
dynamic elements into stable ancestors appear to be viable pro-
tein engineering strategies for improving enzymes or introducing
novel functions. The potential effectiveness of grafting dynamic
loops to introduce novel enzymatic functions has been
discussed35–37 and experimentally demonstrated by the successful
introduction of β-lactamase activity into the αβ/βα metallohy-
drolase scaffold38, thereby generating an enzyme that lacked its
original activity but catalysed hydrolysis of cefotaxime. The
potential of loop remodelling for engineering enzyme functions
has also been illustrated by the deletion of a specific loop and
introduction of a point mutation, leading to emergence of
homoserine lactonase activity in a phosphotriesterase39. The
potential of loop modification in enzyme engineering has also
been discussed in several recent reviews35–37.
There are several preconditions necessary for the application of
our engineering strategy. Ancestral sequence reconstruction
requires about 150 sequences40, but a phylogenetic tree can also
be reconstructed with a lower number of sequences. Mutational
events leading to insertions and deletions make the reconstruc-
tion less reliable41. The InDel mutagenesis strategy is applicable
to any protein of interest, but a screening assay is necessary for
probing a sufficient number of mutants to identify the regions of
interest and to allow robust statistical analysis. For the loop
transplantation strategy, structural information about the pro-
teins is necessary. The strategy is applicable for engineering
a purified from bacterial cultures mammalian cells lysatesb
Fig. 7 Comparison of bioluminescence of enzymes purified from bacterial cultures and in lysates from mammalian cells. a Full decay kinetics of the
conversion of 2.2 μM CTZ by 50 nM of RLuc8, AncINS and AncFT purified from bacterial cultures. The data are presented as relative values to initial
luminescence; AncHLD-RLuc is not plotted due to low activity leading to large signal scattering. Solid lines represent the best fit to the experimental data.
Experiments were repeated independently three times with consistent results. b Bioluminescence signal steadiness in relative values in lysates from
mammalian cells expressing AncFT and RLuc8. Experiments were repeated independently three times with consistent results. Activity was measured using
the commercial Renilla luciferase assay kit (Promega) with 20 μL of cell lysates and 100 μL of assay buffer. Luminescence signal in lysates from mammalian
cells expressing AncHLD-RLuc and AncINS was not detectable under tested conditions. Source data is available as a Source data file for Fig. 7.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23450-z ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:3616 | https://doi.org/10.1038/s41467-021-23450-z | www.nature.com/naturecommunications 9
catalytic efficiency, substrate specificity, and selectivity, and may
enable the design and evolution of multifunctional enzymes. It is
specifically suitable for enzymes with active sites flanked by loops
and enzymes with reaction rates limited by substrate binding or
product release.
In summary, we have developed a strategy for engineering
backbone dynamics based on InDel mutagenesis of a stable
template, multivariate statistics of the data from microscale and
microfluidic experiments, and transplantation of a highly
dynamic element. We validated its utility by an engineering effort
in which catalytic efficiency was increased, and the biolumines-
cence was stabilized to achieve a long-lasting glow-type signal.
The results achieved support the conceptual ideas, which guided
our experiments and stepwise implementation of the strategy.
The developed catalyst can serve as a molecular probe in bacterial
and mammalian cells. The strategy may provide a useful addition
to the repertoire of methods available for engineering catalytically
efficient enzymes40,41 by exploring less travelled parts of protein
sequence space. The loop transplantation strategy is being
implemented in the web application LoopGrafter, which will
make it accessible to a broad community (https://loschmidt.
chemi.muni.cz/loopgrafter/).
Methods
Reagents and procedures used in TRIAD. FastDigest restriction endonucleases,
MuA transposase and T4 DNA ligase were purchased from Thermo Fisher Sci-
entific. DNA Polymerase I, Large (Klenow) Fragment, was purchased from New
England Biolabs. All DNA modifying enzymes were used according to the man-
ufacturer’s conditions. All DNA purification procedures were performed according
to the manufacturers’ instructions using kits, including GeneJET Plasmid Miniprep
kit (Thermo Fischer Scientific) for plasmid extractions from E. coli cells, Zymo-
clean Gel DNA Recovery kit (Zymo Research) for agarose gel extraction of DNA
fragments upon electrophoresis and DNA Clean & Concentrator kit (Zymo
Research) for DNA purification and concentration. Bacterial transformations were
performed by electroporation using E. cloni 10G ELITE electrocompetent cells
(Lucigen).
Generation of insertion and deletion libraries of AncHLD-RLuc using TRIAD.
InDel libraries were prepared following the TRIAD12,42 method. The sequence
encoding AncHLD-RLuc was subcloned from pET21b::ancHLD-RLuc to the TRIAD-
dedicated vector pID-Tet using NdeI and BamHI and yielding pID-Tet::ancHLD-
RLuc. This construct was used as template for the generation of transposition
insertion libraries with engineered TRIAD transposons TransDel and TransIns. The
transposons (~1 kbp) were extracted from pUC57 by BglII digestion and recovered
by gel electrophoresis and purification. Insertion of TransDel or TransIns in pID-
Tet::ancHLD-RLuc (pID-Tet plasmid: ~2.7 kbp; ancHLD-RLuc: ~950 bp) was performed
by in vitro transposition using ~300 ng of plasmid, ~50 ng of transposon and 0.22
μg MuA transposase in a 20 μL reaction volume. After incubation for 2 h at 30 °C,
the MuA transposase was heat-inactivated for 10min at 75 °C. DNA products were
purified and concentrated in 7 μL deionized water. Two microlitres of the purified
DNA was used to transform E. cloni 10G ELITE electrocompetent cells by elec-
troporation. The transformants (~30,000–50,000 CFU) were selected on LB agar
containing ampicillin (amp; 100 μg/mL) and chloramphenicol (cam; 34 μg/mL). The
resulting colonies were pooled, and their plasmid DNA extracted. The fragments
corresponding to ancHLD-RLuc containing the inserted transposon (~2 kbp) were
obtained by double restriction digestion (NdeI/BamHI) followed by gel extraction
and ligated back into pID-Tet (50–100 ng). The ligation products were then
transformed into E. cloni 10G cells. Upon selection on LB-agar-amp-cam, trans-
formants (~1–2 × 106 CFU) were pooled and their plasmid DNA extracted, yielding
TransDel or TransIns insertion libraries depending on the TRIAD transposon used
at the start. For the generation of the triplet nucleotide deletion library of AncHLD-
RLuc, TransDel insertion library plasmids were first digested with MlyI to remove
TransDel. The fragments corresponding to linearized pID-Tet::ancHLD-RLuc (with a
−3 bp deletion in AncHLD-RLuc) were isolated by gel electrophoresis and purified.
Self-circularization was then performed using T4 DNA ligase and 10–50 ng line-
arized plasmid in 50 μL reaction volume (final DNA concentration: ≥1 ng/μL).
Upon purification and concentration, the ligation products were transformed into
electrocompetent into E. cloni 10G cells subsequently selected on LB-agar-amp,
yielding a library of gene of interest variants with random triplet nucleotide dele-
tions. For the generation of the triplet nucleotide insertion library of AncHLD-RLuc,
TransIns insertion library plasmids were first digested with NotI and MlyI to
remove TransIns. The linearized pID-Tet::ancHLD-RLuc plasmids were recovered by
gel electrophoresis and purification. TRIAD cassette Ins1 (containing randomized 3
bp at one extremity and a kanamycin-resistance gene) was extracted from pUC57 by
NotI/MlyI digestion, isolated by gel electrophoresis, purified and inserted into the
linearized pID-Tet::ancHLD-RLuc plasmid (50–100 ng) in a 1:3 molar ratio. After
purification and concentration, these ligation products were transformed into E.
cloni 10G cells and the transformants (~2 × 106 CFU) were selected on LB-agar
supplemented with 100 μg/mL ampicillin and 50 μg/mL kanamycin. The resulting
plasmid ins1 insertion library was then extracted from the transforming colonies
and subsequently digested with AcuI. The linearized pID-Tet::ancHLD-RLuc plasmids
(with a 3 bp insertion) were recovered by gel electrophoresis, purified and subse-
quently treated with the Klenow fragment of DNA Polymerase I to remove 3′
overhangs created by AcuI digestion. After that blunting step, the plasmids were
self-circularized. The resulting ligation products were transformed into electro-
competent E. cloni 10G cells subsequently plated on LB-agar-amp, yielding libraries
of AncHLD-RLuc variants with random triplet nucleotide insertions (one per variant).
The same procedure was applied to generate a second-round triplet nucleotide
insertion library of AncINS. All the libraries were purified and stored in the form of
plasmid solutions prior to transformation into E. coli for protein variant expression
and screening. Plasmid DNA from 10 randomly selected colonies from all three
libraries were sequenced for quality control (Eurofins Genomics, Germany).
Point mutagenesis of RLuc8. Site-directed PCR-based mutagenesis was applied to
create rLuc8-W121F/E144Q in two steps using QuikChange site-directed muta-
genesis kit via manufacturer’s protocol (Agilent, USA). First, rLuc8-W121F was
created using oligonucleotides RLuc8-W121F-FWD1 and RLuc8-W121F-RVS1
with rLuc8 gene serving as a template. Then rLuc8-W121F gene was used as a
template to create rLuc8-W121F/E144Q using RLuc8-E144Q-FWD2 and RLuc8-
E144Q-RVS2. Error-free clones were confirmed by DNA sequencing (Eurofins
Genomics, Germany). Mutagenic primers are available in Supplementary Table 8.
Transplantation of secondary structure elements. The AncHLD-RLuc and
RLuc8 sequences were aligned using Jalview43 and T-coffee44 with default settings
(Supplementary Fig. 9). The construct pET21b::ancHLD-RLuc (NdeI/BamHI) was
chosen as a template for mutagenesis using Phusion® High-Fidelity DNA Poly-
merase according to the manufacturer’s protocol (New England BioLabs, USA).
Mutagenic primers (Supplementary Table 8) (Sigma-Aldrich, USA) were designed
manually for two separate PCR runs (Supplementary Fig. 16). In the next step, a
standard fusion PCR protocol was used to fuse DNA fragments from the first two
PCR runs. The resulting fused DNA fragment was cloned into pET21b or pID-Tet
vectors. The error-free status of the clones was confirmed by sequencing (Eurofins
Genomics, Germany).
Cultivation of InDel libraries in 96-well plates. Chemocompetent Escherichia
coli BL21 cells (♯C2530H, New England BioLabs, USA) were transformed with the
ancHLD-RLuc insertion/deletion library (in the pID-Tet vector) and grown on LB
agar plates containing 100 μg/ml ampicillin overnight at 37 °C. The cells trans-
formed with the vector pID-Tet (lacking an insert) and pID-Tet::ancHLD-RLuc were
used as negative and positive controls, respectively, when screening the libraries.
Single colonies of transformed cells carrying InDel variants of ancHLD-RLuc were
transferred into sterile 96-well plates containing 150 μl LB medium with 100 μg/ml
ampicillin in each well. The plates were covered with AeraSealTM film (Sigma-
Aldrich, USA) and incubated for 15 h at 37 °C under shaking at 200 rpm. After
cultivation, 100 μl of the culture was transferred into new microtiter plates (MTPs)
and 100 μl of fresh LB medium with 100 μg/ml ampicillin and anhydrotetracycline
(to a final concentration 200 ng/ml) was added to each well. To make replica plates
to be stored at −70 °C, 50 μl of 30% glycerol was added to the remaining 50 μl of
the culture. The MTP was incubated at 30 °C and 200 rpm for 4 h. Cell cultures
were harvested by centrifugation at 1600 × g for 20 min. The supernatant was
discarded and the MTP was frozen at −70 °C. Before screening of the libraries,
MTPs were defrosted and kept at laboratory temperature for 10 min. Then, 70 μl of
lysis buffer (20 mM potassium phosphate, 20 mM Na2SO4 and 1 mM EDTA, pH
8.0) containing lysozyme (1 mg/ml) was added to each well. Cell debris was
removed from the lysate by centrifugation at 1600 × g for 20 min after incubation at
23 °C and 100 rpm for 1 h. Robotic cultivation and cell lysis were performed
analogously to the manual screening described above using a colony picking robot
(Colony Picker, Molecular Devices QPix 420), a liquid handling robot (Bravo,
Agilent) with a 96-tip head and the LARA robotic system (Greifswald, Germany).
Screening of luciferase activity in 96-well plates. Luciferase activity was mea-
sured using a previously described procedure14, with adaptation, in both the
manual and robotic screenings. For manual screening, 30 μl of cell lysate was
transferred into a new MTP and 220 μl of assay buffer (100 mM potassium
phosphate, 1 mM Na2SO4, pH 7.5) with 2.2 μM coelenterazine (CTZ) was added.
The luminescence signal was immediately measured for 22 s with the gain value set
to 3250. Before the addition of the assay buffer with CTZ, the sample’s baseline
luminescence signal was measured for 10 s. Luminescence was measured at 30 °C in
a FLUOstar OPTIMA Microplate Reader (BMG Labtech, Germany). Luciferase
activity was expressed in relative light units (RLU) s−1 mg−1 of an enzyme14. The
RLUs were integrated over the first 72.5 s immediately after injection of the sub-
strate into the enzyme solution.
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For robotic screening, 50 μl of cell lysate was pipetted by a Liquid Handling
Robot into a new white MTP (Nunc™ F96 MicroWell™ White Polystyrene Plate,
Nunclon Delta Surface, Thermo Fisher Scientific) and the reaction was initiated by
adding 50 μl of a CTZ stock solution (1 mg of CTZ dissolved in 2 ml of pure EtOH)
diluted 1000x in MilliQ water. The luminescence signal was measured using a
VarioscanLUX reader (Thermo Fisher Scientific, SkanIt Software 4.1 for Microplate
Readers RE, ver. 4.1.0.43). Each measurement consisted of 50 readings, each of
which took 200 ms (standard optics, automatic dynamic range). The CTZ solution
was dispensed during reading 15 at a moderate dispensation speed. Luciferase
activity was expressed in relative light units (RLU) s−1 mg−1 of an enzyme14.
Screening of dehalogenase activity in 96-well plates. Haloalkane dehalogenase
activity measurements were based on a pH assay45 according to Holloway and co-
workers45. The principle of the assay is based on the detection of protons produced
during the dehalogenation reaction. Substrate 1-bromobutane (100 μl) was incu-
bated in the reaction buffer (200 ml; 1 mM HEPES, 20 mM Na2SO4, 1 mM EDTA
and 25 μg/ml phenol red, pH 8.2) at 37 °C for 30 min. Fifteen microlitres of cell
lysate was transferred into new MTP and 185 μl of assay buffer with 1-
bromobutane were added. The MTP plate was properly closed by the Adhesive film
for microplates (VWR, USA) and incubated at laboratory temperature for 15 h.
The change in colour of pH indicator was measured at 540 nm by using an Eon
spectrometer (BioTek, USA).
Overproduction and purification of AncHLD-RLuc variants. AncHLD-RLuc variants
were overexpressed from pID-Tet (ampR) in E. coli BL21 cells (#C2530H, New
England BioLabs, USA) cultivated in LB medium supplemented with ampicillin
(100 μg/ml) at 37 °C. Protein production was induced under the TET promotor at
20 °C once the OD600 reached ~0.5 by adding anhydrotetracycline (Cayman
Chemical, USA) to a final concentration of 200 ng/ml. At small scale, proteins were
purified using the MagneHisTM Protein Purification System (Promega, USA),
dialysed using a Slide-A-LyzerTM MINI Dialysis Device (Thermo Scientific, USA),
and their purity was verified by SDS-polyacrylamide gel electrophoresis. At large
scale, proteins were purified by affinity chromatography targeting their C-terminal
hexahistidine tags. The monomer fraction was separated on a HiLoadTM 16/600
SuperdexTM 200 pg column (GE Healthcare, UK) equilibrated with 100 mM
potassium phosphate buffer (pH 7.5). All enzymes were concentrated using
AmiconR Ultra-15 UltracelR−10K Centrifugal Filter Units (Merck Millipore Ltd.,
Ireland). The purity of all enzyme preparations was checked by SDS-
polyacrylamide gel electrophoresis; in all cases, only one band corresponding to the
monomer fraction was visible.
Large-scale overproduction and purification of RLuc8-W121F/E144Q. The E.
coli BL21 (DE3) (C2527H, New England BioLabs, USA) cells were transformed by
the heat shock method with the plasmid pET21b::rLuc8-W121F/E144Q.
Ampicillin-resistant colonies were inoculated in LB medium (10 ml) (1xLB med-
ium, ampicillin 100 μg/ml), which was incubated (200 rpm) overnight at 37 °C. On
the next day, a bacterial culture was used to inoculate 5-liter Erlenmeyer flasks
containing 1 liter of 1xLB medium with ampicillin (100 μg/ml) where cells were
grown (200 rpm, 37 °C) until the culture reached OD600= 0.5. Induction of
expression was done at 22 °C by adding 0.5 ml of 1M IPTG, and the culture was
then incubated overnight (typically 12–16 h) at 22 °C/115 rpm. Next day, the
bacterial biomass was harvested by centrifugation (3000 × g/10 min/4 °C) and re-
suspended in a purification buffer (500 mM NaCl, 20 mM potassium phosphate
buffer pH 7.5, 10 mM imidazole) and lysed by sonication (50% amplitude, 32 min
(5 s pulse/5 s pause) using a sonicator Sonic Dismembrator Model 705 (Fisher
Scientific, USA). The sonicated lysate was clarified by centrifugation (21,000 × g, 60
min, 4 °C). The supernatant was then collected, filtered and applied on Ni-NTA
Superflow Cartridge (Qiagen, Germany) column equilibrated with the purification
buffer. The target enzyme was eluted by a linear gradient of the purification buffer
supplemented with 300 mM imidazole. The eluted protein fractions of RLuc8-
W121F/E144Q were pooled and dialysed overnight against 100 mM NaCl, 10 mM
Tris-HCl pH= 7.0. The dialysed protein was subsequently loaded onto 16/60
Superdex 200 gel filtration column (GE Healthcare, UK) pre-equilibrated with the
corresponding buffer. The purified RLuc8-W121F/E144Q protein was con-
centrated with an Amicon Ultra centrifugal filter units (Millipore, USA), and
protein concentrations were assayed by the DS-11 Spectrophotometer
(DeNovix, USA).
Mammalian cells experiments. NIH/3T3 mouse fibroblast cells (ATCC® CRL-
1658™) were transfected according to manufacturer’s protocol using Lipofectamine
2000 (Thermo Fisher, USA) with pcDNA3.1(+) plasmids containing genes codon-
optimized for expression in mammalian cells (Gene Art, Thermo Fisher, USA).
Cells were lysed 24 h after transfection and luciferase activity was measured in
lysate via Microplate Reader FLUOstar Omega (BMG Labtech, Germany) using a
commercial Renilla Luciferase Assay System (Promega, USA) and also using an in-
house prepared assay buffer 100 mM PBS pH= 7.5 with 4.5 μM CTZ (final con-
centration in the reaction mixture). Cells transfected with pcDNA3.1(+) plasmid
were used as a negative control. The measurements were done in triplicates.
Circular dichroism spectroscopy. Circular dichroism (CD) spectra were recorded
at 20 °C using a Chirascan spectropolarimeter (Applied Photophysics, UK). Data
were collected from scans of the focal proteins from 185 to 260 nm at 100 nm/min
with a 1 s response time and 1 nm bandwidth in 0.1 cm quartz cuvettes. Each
presented spectrum (Fig. S13) is an average of five individual scans, corrected for
absorbance of the buffer. The CD data were expressed in terms of mean residue





where Θobs is the observed ellipticity in degrees, Mw is the scanned protein’s
molecular weight, n is the number of residues, l is the cell path length, c is the
protein concentration (in mg/ml) and the factor of 100 originates from the con-
version of the molecular weight to mg/dmol.
Thermal stability. Thermal unfolding was studied by using a NanoDSF Pro-
metheus instrument (NanoTemper, Germany) to monitor Trp fluorescence during
heating at 1 °C/min from 20 to 90 °C. The melting temperatures (Tonset and Tm)
were evaluated directly by ThermControl v2.0.2.
Microfluidic determination of temperature profiles and thermodynamics.
Temperature profiles of specific activities of individual enzyme variants towards the
substrate 1,3-dibromopropane were measured in 2.5 °C increments from 20 to 40 °
C using a capillary-based droplet microfluidic platform, enabling characterization
of enzymatic activity within droplets for multiple enzymes in a single run46. The
droplets were generated using the Mitos Dropix (Dolomite, UK). A custom
sequence of droplets (150 nl aqueous phase, 300 nl oil spacing) was generated using
negative pressure (microfluidic pump) and the droplets were guided through
polyethylene tubing to the incubation chamber. Within the incubation chamber,
the halogenated substrate was delivered to the droplets via a combination of
microdialysis and partitioning between the oil (FC 40) and the aqueous phase. The
reaction solution consisted of a weak buffer (1 mM HEPES, 20 mM Na2SO4, pH
8.2) and a complementary fluorescent indicator 8-hydroxypyrene-1,3,6-trisulfonic
acid (50 μM HPTS). The fluorescence signal was obtained by using an optical setup
with excitation laser (450 nm), a dichroic mirror with a cut-off at 490 nm filtering
the excitation light and a Si-detector. By employing a pH-based fluorescence assay,
small changes in the pH were observed and enabling monitoring of the enzymatic
activity. The reaction progress was analysed as an end-point measurement recor-
ded after passing of 7 or 10 droplets/sample through the incubation chamber. The
reaction time was 4 min. The raw signal was processed by a droplet detection
script46 written in MATLAB 2017b (Mathworks, USA) to obtain the specific
activities. Natural logarithms of the specific activities were used in subsequent
thermodynamic analysis to generate both Arrhenius and Eyring plots and to derive
thermodynamic parameters (Supplementary Fig. 1).
Anisotropic network modelling. Secondary structure elements were defined in
AncHLD-RLuc and RLuc8 based on their respective crystal structures (PDB ID 6G75,
chain A; and 2PSF, chain B) using DSSP47 followed by manual edition after visual
inspection (Supplementary Tables 2, 3). Anisotropic network models were com-
puted using the Prody 1.10.8 standalone package48 and the position-specific vector
of squared fluctuations and matrix of motion cross-correlations were obtained.
These matrices were further extended by calculating the averaged cross-correlation
values corresponding to each secondary structure element. To facilitate distinction
of differences in predicted motions, the matrix calculated for RLuc8 was subtracted
from that calculated for AncHLD-RLuc. The final matrix M encompassed values
ranging from −2 (motions more cross-correlated in RLuc8) to 2 (motions more
cross-correlated in AncHLD-RLuc), where values close to 0 indicate similar motions
in the two structures. To improve understanding of effects of mutations on the
25 selected variants, the positions and secondary structure elements of mutations
resulting in extreme values were mapped to both reference crystals (AncHLD-RLuc
and RLuc8) based on their alignment (Supplementary Fig. 9). Then, three groups of
interesting regions were defined and used to annotate each variant with 18 values
obtained from matrix M: nine for the cross-correlation of motions of the specific
position and nine for the secondary structure element.
Calculation of segment-centred cross-correlation values from ANM. Let i1 and
i2 be the indices of the beginning and ending position of a given secondary
structure element (SSEi) in the structure for which the ANM is computed; j1 and j2
be the indices of the beginning and ending position of a different secondary
structure element (SSEj) on the same structure; var(x) and var(y) be the squared
fluctuation value for the xth and yth residue on the structure, respectively; and r(x,
y) the cross-correlation value for the pair formed by the xth and yth residues on the
structure obtained from the same ANM calculation. The averaged cross-correlation
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value for the pair (SSEi, SSEj) can be calculated according to Eq. (2).
Ccor SSEi; SSEj
  ∑x¼i2x¼i1 ∑y¼j2y¼j1 r x; y
  ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
var xð Þ  var y q ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
∑x¼i2x¼i1 ∑
y¼i2
y¼i1 r x; y
  ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
var xð Þ  var y q :∑x¼j2x¼j1 ∑y¼j2y¼j1 r x; y
  ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
var xð Þ  var y q
r
ð2Þ
Note that if additionally to the E SSEx elements defined in each of the
Supplementary Tables S2, S3, each of the P amino-acids of each analysed protein is
considered as one of such elements, the dimension of the resulting cross-
correlation matrix is (E+ P)2. Such matrix would be formed by two diagonal
matrices with dimensions E2 and P2 representing the SSE to SSE and amino-acid to
amino-acid cross-correlations, respectively; and by two mirroring rectangular
matrices (E × P and P × E) representing the amino-acid to SSE cross-correlations.
Multivariate statistical analysis. Partial least squares (PLS) regression analysis49
was used to explore relationships between structural and molecular variables (X) of
the proteins and their enzymatic activities (Y), all of which were autoscaled and
centred. The complete data matrix used in the PLS analysis is provided in Source
data file. Variable importance in the projection (VIP)50 and variable weight plots51
were used to assess the importance of every descriptor in the model, with further
validation by cross-validation49 and permutation testing. During the cross-
validation procedure, parts of the Y data are not considered during model building,
and the ability of the resulting model to predict those data is assessed by comparing
predicted and actual values, providing cross-validated Q2 values. In this study, 1/7
of the mutants were deleted in each cross-validation round. In the permutation
testing, the model was recalculated 999 times with a randomly re-ordered
dependent variable. SIMCA-P version 12 (Umetrics, Umea, Sweden) was used for
statistical analyses.
Success rate frequency analysis. Luminescence readings were processed to
determine each tested variant’s luciferase activity relative to the mutagenesis
template. Each microtiter plate used for this analysis included negative and positive
controls (in sets of four wells) as well as the tested variants, and transformations
were applied to obtain relative activities of the preparation in each well. First, the
negative control wells were averaged time-point by time-point. Second, the rest of
the wells were blanked using subtracting from each of their time-point values of the
corresponding averaged time-point from the negative controls. Third, two seg-
ments for each data series were defined: pre- and post-injection of the coelenter-
azine substrate, which occurred ten seconds after the beginning of the readings on
the FLUOstar OPTIMA instrument. The pre-injection series consisted of all data
points before injection time. The post-injection series consisted of all data points
collected from the moment the reading of the signal was stable (0.2 s after the
injection time) until the end of the readings. From each data series, outliers defined
as Q1− 1.5*(Q3−Q1) and Q3+ 1.5*(Q3−Q1) (where Q1 and Q3 represent the
first and third quartile values of each distribution) were omitted to remove noise
from the data. Fourth, the average value of the pre-injection series was subtracted
from the average value of the post-injection one, to obtain the raw intensity value
of each well. Fifth, the reference intensity value of the plate was calculated by
averaging the raw intensity values of the positive control wells. Sixth, the relative
intensity value was calculated as the ratio of the raw intensity value of each well
over the reference intensity value of the plate.
Steady-state kinetics measurement and data analysis. Solid coelenterazine was
dissolved in ice-cold ethanol and stored under nitrogen atmosphere in dark glass
vials at –20 °C. Before measurement, concentration and quality of the ethanol stock
solution were verified spectrophotometrically. Series of buffer solutions with dif-
ferent coelenterazine concentration was prepared by manual injection of an
appropriate volume of the ethanol stock solution into 10 ml of 100 mM phosphate
buffer pH 7.5 immediately before the measurement. The reaction mixture was
composed of 10% (v/v) enzyme solution in 100 mM phosphate buffer pH 7.5 and
90% (v/v) of buffer solution of coelenterazine. All reactions were carried out at 37 °
C in microtiter plates using the microplate reader FLUOstar OPTIMA (BMG
Labtech, Germany) set to broad-spectrum luminescence reading. Microplate well
with pre-pipetted 25 μl of enzyme solution was first monitored for background
light for 10 s, after which, 225 μl of a buffer solution with coelenterazine was added
via an automatic syringe. The luminescence of the reaction mixture was then
measured for the desired time until the luminescence intensity decreased under
0.5% of its maximal measured value. Each reaction was performed in three repe-
titions. The gain of the reader was tailored to each enzyme separately, however, for
each enzyme, all readings at different substrate concentrations were obtained using
the same gain value.
An updated protocol applying new standards for collecting and fitting steady-
state kinetic data52,53 was used. Unlike the classical initial velocity analysis, which
requires a sophisticated luminometer calibration and quantum yield evaluation to
obtain complete kinetic data54, luminescence data were recorded when letting the
reaction proceed to completion beyond the initial linear phase. The recorded
luminescence traces (rate vs. time) were transformed to reaction progress curves
corresponding to cumulative luminescence in time (Supplementary Fig. 5). The
transformed steady-state kinetic data (product vs. time) were fitted globally by
numerical methods with the KinTek Explorer (KinTek Corporation, USA) to
obtain direct estimates of turnover number kcat, Michaelis constant Km, specificity
constant kcat/Km, and equilibrium dissociation constant for enzyme-product
complex Kp with no need for luminometer quantum yield calibration. The software
allows for the input of a given kinetic model via a simple text description, and the
programme then derives the differential equations needed for numerical
integration automatically. Numerical integration of rate equations searching a set
of kinetic parameters that produce a minimum χ2 value was performed using the
Bulirsch–Stoer algorithm with adaptive step size, and nonlinear regression to fit
data was based on the Levenberg–Marquardt method55. To account for
fluctuations in experimental data, enzyme or substrate concentrations were slightly
adjusted (±5%) to derive best fits. Residuals were normalized by sigma value for
each data point. The standard error (S.E.) was calculated from the covariance
matrix during nonlinear regression. In addition to S.E. values, more rigorous
analysis of the variation of the kinetic parameters was accomplished by confidence
contour analysis by using FitSpace Explorer (KinTek Corporation, USA). In these
analyses, the lower and upper limits for each parameter were derived
(Supplementary Table 4) from the confidence contour obtained from setting χ2
threshold at 0.956. The scaling factor, relating luminescence signal to product
concentration, was applied as one of the fitted parameters, well constrained by end-
point levels of kinetic traces recorded at particular substrate concentrations.
Depletion of the available substrate after the reaction was ensured by repeated
injection of the fresh enzyme. The steady-state model (Eqs. (3)–(6)) was used to
obtain the values of turnover number kcat, Michaelis constant Km and equilibrium
dissociation constant for enzyme-product complex Kp. A conservative estimate for
diffusion-limited substrate and product binding k+1 and k−3 (100 μM−1.s−1) was
used as a fixed value to mimic rapid equilibrium assumption. An alternative form











kcat ¼ kþ2 ð4Þ
Km ¼ k1=100 ð5Þ
Kp ¼ kþ3=100 ð6Þ





kcat=Km ¼ kþ1 ð8Þ
Bioluminescence decay kinetics. Bioluminescence decay kinetics were monitored
in the same conditions as the steady-state kinetics, with final concentrations of 2.2
μM CTZ and 50 nM enzyme. The obtained luminescence kinetic data were fitted to
an exponential decay or logistic model using Origin 6.1 (OriginLab, USA) to obtain
the half-life t1/2 of the luminescence signal.
Transient kinetics of substrate binding experiments and data analysis.
Transient kinetic traces of the protein variants were monitored after rapidly mixing
components in 100 mM potassium phosphate buffer (pH 7.5) using the Stopped-
Flow SFM 3000 mixing system and the MOS-500 spectrometer (BioLogic, France).
In each case, the reaction was initiated by mixing 75 µl of an enzyme solution with
75 µl of CTZ solution and then monitored by the changes of fluorescence at 340 ±
13 nm after excitation at 295 nm. In experiments with each protein variant, con-
centrations of the CTZ substrate and an enzyme were separately varied in sets of
seven consecutive replicates and the resulting kinetic traces were averaged. The
experiments were based on monitoring changes in native tryptophan fluorescence
that was quenched by the coelenterazine substrate upon its binding by an enzyme.
The drop of the initial fluorescence level caused by the non-specific interactions
and inner filter effects of coelenterazine was corrected based on experiments with
bovine serum albumin, which exhibited the same initial decrease of the fluores-
cence signal. At room temperatures, the kinetics of the substrate binding was too
fast, and most of the kinetic information was lost in the dead time of the instru-
ment (0.3 ms). After decreasing the temperature down to 15 °C, kinetic traces
collected for AncINS, AncFT and RLuc8 exhibited a triple-exponential decay of the
fluorescence signal.
The two initial kinetic phases related to the binding of the substrate were fit
with a double exponential equation (Eq. (9)) for each fluorescence trace
(Supplementary Fig. 8). The dependence of the observed rates on the substrate
concentration for both the fast and the slow kinetic phases were fit according to the
induced-fit (IF) mechanism (Eqs. (10)–(12)) and the conformational selection (CS)
mechanism (Eqs. (13)–(15)), assuming that k−1 >> k−2, k+257. The obtained values
were used as initial estimates of the elementary rate constants describing the
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binding process.










kfast;IF ¼ kþ1  S½  þ k1 ð11Þ
kslow;IF ¼
kþ2  kþ1k1  ½S
kþ1
k1











kfast;CS ¼ kþ2  S½  þ k1 ð14Þ
kslow;CS ¼
kþ1  kþ1k1  kþ2  S½  þ k2
 
kþ1  kþ1k1  kþ2  S½  þ k2
ð15Þ
In the case of AncHLD-RLuc, the kinetic traces exhibited slow equilibration with
low signal amplitudes, resulting in a limited precision of analysis (Supplementary
Fig. 8). The data could be fit with only a single exponential equation (Eq. 16), and
the dependence of the observed rate constant and the amplitude on the substrate
concentration were fit according to a one-step binding mechanism (Eqs. (17)–
(19)). Such a result pointed out that the rigidified ancestral enzyme shows no
profound conformational flexibility and that only a simple substrate binding could
be detected.






kobs ¼ kþ1  S½  þ k1 ð18Þ
A ¼ Alim  ½S
Kd þ S½ 
ð19Þ
The original raw kinetic data with residuals normalized by sigma values were
subsequently analysed globally by numerical simulation using the KinTek Explorer
software (KinTek Corporation, USA)52,55,56 and following the same protocol as
described in the steady-state kinetics section. The time-course of the fluorescence
quenching upon substrate binding was described with Eqs. (20)–(22) for the induced-
fit, conformational-selection, and one-step binding mechanisms, respectively. The
estimates of the rate constants obtained by analytical fitting were used as starting
points, and the final values were obtained by fitting the mechanism directly to the
collected kinetic data. The quality of the best fits for different mechanisms was
compared in terms of χ2 value, “chi-by-eye” assessment, and confidence contour
analysis assessing constraint and independency of the determined parameters. Based
on this analysis, the correct mechanism of the substrate binding and the respective
elementary rate constants were identified. Lower and upper limits for each parameter
were derived for the χ2 threshold of 0.9556.
FIF ¼ f  ½E þ a  ½ES þ b  ½E*S
 
ð20Þ
FCS ¼ f  ½E þ a  ½E* þ b  ½E*S
 
ð21Þ
Fonestep ¼ f  ½E þ a  ½ESð Þ ð22Þ
Hydrogen/deuterium exchange (HDX) mass spectrometry. Enzyme samples
were diluted with 100 mM phosphate buffer in H2O (pH 7.5) to prepare undeut-
erated controls and for peptide mapping, or with 100 mM phosphate buffer in D2O
(pD 7.1) to prepare deuterated samples. The final concentrations of the enzyme
samples used for analysis was 2 µM. HDX was carried out at room temperature and
was quenched after 10, 60 or 300 s by adding 1M HCl in 1M glycine with pepsin.
Each sample was directly injected into an LC-system (UltiMate 3000 RSLCnano,
Thermo Fisher Scientific, USA) with an immobilized nepenthesin enzymatic col-
umn (Affipro, CZ; 15 µl bed volume, flow rate 20 µl/min, 2% acetonitrile/0.05%
trifluoroacetic acid). Peptides were trapped and desalted on-line on a peptide
microtrap (Michrom Bioresources, CA) for 3 min at a flow rate of 20 µl/min. Next,
the peptides were eluted onto an analytical column (Jupiter C18, 1.0 × 50 mm, 5
µm, 300 Å, Phenomenex, CA) and separated by linear gradient elution starting
with 10% buffer A in buffer B and rising to 40% buffer A over 2 min. This was
followed by 31 min isocratic elution at 40% B. Buffers A and B consisted of 0.1%
formic acid in water and 80% acetonitrile/0.08% formic acid, respectively. The
immobilized nepenthesin column, trap cartridge, and analytical column were kept
at 1 °C using a refrigerated system (Science Instruments and Software, CZ).
Mass spectrometric analysis was carried out using an Orbitrap Elite mass
spectrometer (Thermo Fisher Scientific, USA) with ESI ionization connected on-
line to a robotic system based on the HTS-XT platform (CTC Analytics,
Switzerland). The instrument was operated in a data-dependent mode for peptide
mapping (HPLC-MS/MS). Each MS scan was followed by MS/MS scans of the
three most intensive ions from both CID and HCD fragmentation spectra. Tandem
mass spectra were searched using SequestHT against the cRap protein database
(ftp://ftp.thegpm.org/fasta/cRAP) containing the sequences of Rluc8, AncHLD-RLuc
and the studied mutants with the following search settings: mass tolerance for
precursor ions of 10 ppm, mass tolerance for fragment ions of 0.6 Da, no enzyme
specificity, two maximum missed cleavage sites and no-fixed or variable
modifications. The false discovery rate at the peptide identification level was set to
1%. Sequence coverage was analysed with Proteome Discoverer version 1.4
(Thermo Fisher Scientific, USA) and graphically visualized with the MS Tools
application58. Analysis of deuterated samples was done in HPLC-LC-MS mode
with ion detection in the orbital ion trap. The MS raw files together with the list of
peptides (peptide pool) identified with high confidence characterized by requested
parameters (amino acid sequence of each peptide, its retention time, XCorr, and
ion charge) were processed using HDExaminer version 2.2 (Sierra Analytics, CA).
The software used to analyse protein and peptide behaviour, creates the uptake
plots that measured peptide deuteration over time with the calculated confidence
level.
HDX mass spectrometry data analysis. The acquired data were analysed as
follows. The raw MS files together with the list of peptides (peptide pool) identified
with high confidence characterized by requested parameters (retention time,
XCorr, and charge) were processed using HDExaminer version 2.2 (Sierra Ana-
lytics, Modesto, CA). The software analysed the proteins’ and peptides’ behaviour
and generated uptake data that were mapped to the proteins’ amino acid sequences
via the following procedure. Each residue was assigned the uptake data from any
peptide solved with high confidence. Medium confidence peptides were also
accepted for positions without previously assigned data. Low confidence peptides
were rejected. The final uptake value (expressed as % of deuteration) assigned to
each amino acid corresponded to the average of all assigned values for its position.
MD simulations. MD simulations were carried out on the crystal structures of
RLuc8 (PDB ID 2PSF17), AncHLD-RLuc (PDB ID 6G7514), AncINS (PDB ID 6S6E)
and AncFT (PDB ID 6S97). Hydrogen atoms were added to the structures using
the H++ web server59, at pH 7.5. Water molecules from the crystal structures,
which did not overlap with the protonated structures, were retained. The systems
were solvated using the solvate module of high-throughput molecular dynamics
(HTMD) in a cubical water box of TIP3P water molecules so that all atoms were at
least 10 Å from the surface of the box60. Cl− and Na+ ions were added to neutralize
the protein’s charge and get a final concentration of 0.1 M. In all the simulations
periodic boundary conditions were applied, the particle mesh Ewald method was
used to treat interactions beyond a 9 Å cut-off, electrostatic interactions were
suppressed >4 bond terms away from each other, and the smoothing and switching
of van der Waals and electrostatic interactions were cut-off at 7.5 Å61. HTMD was
used for adaptive sampling of the RMSD of the Cα atoms of residues 10–290. The
production runs (20 ns) were started with the files resulting from the equilibration
using settings from the final equilibration step. The trajectories were saved every
100 ps. The adaptive epochs were updated every 6 h to run with a minimum of five
simulations and a maximum of 10 simulations for the total maximum of 110
epochs using TICA in 1 dimension62.
Equilibration of systems for MD simulations. The systems were equilibrated
using the Equilibration_v2 module of HTMD 1.23.459. The system was first
minimized using the conjugate-gradient method for 500 steps, after which the
system was heated and minimized as follows (i) 500 steps (2 ps) of NVT heating,
with the Berendsen barostat, to 310 K, with constraints on all heavy atoms of the
protein; (ii) 2.5 ns of NPT equilibration, with the Langevin thermostat, with 1 kcal
mol−1 Å−2 constraints on all the heavy atoms of the protein; and (iii) 2.5 ns of
NPT equilibration, with the Langevin thermostat, without constraints. During the
equilibration simulations, holonomic constraints were applied to all hydrogen-
heavy atom bond terms and the mass of hydrogen atoms was scaled by a factor of
4, enabling the use of a 4 fs timestep60,61. This approach transfers some mass from
the heavy atom to the hydrogen to slow the fastest vibrations in the hydrogen atom,
which is acceptable because the thermodynamic properties of biological systems are
insensitive to the distribution of atomic masses63,64.
Adaptive sampling. Adaptive sampling here refers to the MD method that per-
forms simulations in small sequential batches of 10 simulations. Before the next
batch of simulations is submitted, the first batch is analysed considering a certain
parameter (RMSD in this study) and the less sampled conformational regions are
used to start a new batch. This way the method ensures that the sampled regions
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are maximized. This sampling analysis is done using Markov state models making
a list of metastable states distributed through the conformational space.
Calculation of B-factors. B-factors were calculated from all snapshots obtained
from the MD simulations for the backbone atoms of each enzyme. The Metric
Fluctuation tool from the HTMD package was used to calculate the RMSF, from
which B-factors were calculated using Eq. (23).





The B-factors obtained from the MD simulations were standardized for each
enzyme to enable comparisons between enzymes. This was done using Eq. (24).
Z ¼ X  μ
δ
ð24Þ
Here, Z is the standardized value, X is the original B-factor value, μ is the
average of the B-factors, and δ is the sample standard deviation. The simulations
were made into a simulation list using HTMD, water was filtered out, and crashed
simulations with lengths below 20 ns were omitted59. The total simulation time
required for the calculations was in excess of 4 μs for each enzyme. The dynamics
of the enzymes were evaluated based on the RMSD of the Cα atoms of residues
10–290 to avoid problems due to the misleadingly high RMSD values of the
dynamically free residues at each end of the protein. The data were clustered into
200 clusters using the MiniBatchKmeans algorithm. The implied timescale plot
(based on a Markov state model with various lag times) was constructed to select a
lag time for Markov model construction, using the RMSD of the full protein as a
metric. Because the timescales mostly stabilized after 15 ns lag time, this value was
used in the models to construct the 2 Markov states (open and closed). The final
data were calculated from 1000 bootstrapping runs using 50% of the data.
Tunnel calculations. The tunnels were calculated with Caver 3.0223 using 1000
random frames belonging to each state using Caver Analyst 2.0.3165, with Probe
radius: 0.9 Å, clustering threshold: 5, shell depth: 5 Å and shell radius: 5 Å. For the
AncHLD-RLuc the starting point of the tunnel was defined by: ND2 of the Asn51 and
OE1 of Glu142. For other enzymes, the starting point was defined by ND2 and OE1
in analogous residues.
Cavities calculations. The cavity calculations for the four proteins were carried
out in the duplicates using the software Caver Analyst 2.0.3165. We have used 100
random snapshots to obtain the cavity volumes from the open conformations and
100 random snapshots from the closed conformations. A probe of 1.4 Å was used
for the cavities and a maximum probe size of 3.0 Å was used to delimit the interface
between solvent and cavity. The same parameters for the probes were used when
calculating the cavity volume of the crystal structures. When two chains were
present, the cavities were calculated for both chains. Cavities were also calculated
for the minimized crystal structures, both chains when present.
Crystallizations. Diffraction-quality crystals of AncINS were obtained using the
sitting-drop vapour diffusion technique in a 96-well crystallization plate (UVXPO
2 Lens Crystallization Plate, SWISSCI, Switzerland) at 20 °C after 5 days by mixing
equal volumes of AncINS (4.5 or 10.5 mg/ml) with the reservoir solution from
Morpheus crystallization screen condition C5, which consists of 0.09 M NPS
additive mix (sodium nitrate, sodium phosphate dibasic, ammonium sulfate) and
0.1 M buffer system 2 (sodium HEPES, MOPS) at pH 7.5 with 30% v/v precipitant
mix 1 (PEG 500 MME, PEG 20,000). The crystals were fished out and directly
flash-frozen in liquid nitrogen for diffraction analysis at ESRF beamline ID23-1 in
Grenoble (France).
AncFT crystals were obtained using the hanging-drop vapour diffusion
technique in EasyXtal 15-well plates (Qiagen, Germany) with seeding at 20 °C after
2 days by mixing 0.5 µl of seed, 2 µl of AncFT (9.2 mg/ml), and 1 µl of reservoir
solution (0.2 M sodium acetate, 0.1 M Tris pH 8.5, 19% PEG 3350). Crystals were
cryo-protected with 20% glycerol and flash-cooled in liquid nitrogen.
Crystallographic data were collected at cryogenic temperature at SLS beamline
PXIII in Villigen (Switzerland), with wavelength of 1 Å.
Prior to the co-crystallization screening, the purified protein RLuc8-W121F/
E144Q was concentrated to 6.0 or 8.5 mg/ml and mixed with 3–5 molar excess of
coelenterazine (stock solution of coelenterazine was 11.8 mM in isopropanol). The
mixture was incubated 1 h at 4 °C, and then precipitated material was removed by
centrifugation (13,000 rpm/10 min/4 °C), and the supernatant containing enzyme-
ligand complexes was directly crystallized. The crystallization was performed in
Easy-Xtal 15-well crystallization plates in a hanging drop vapour diffusion
technique, where enzyme-ligand drops (typically 1.5 μl) were mixed with the
reservoir solution (2.2 M NaHPO4/K2HPO4, 0.1 M sodium acetate pH= 4.5) in the
ratio 1:1 and equilibrated against 500 μl of the reservoir solution. Diffraction
quality crystals of RLuc8-W121F/E144Q were obtained at 20 °C after 3–5 days. All
crystals used for X-ray diffraction analysis were flash-frozen in liquid nitrogen in
the corresponding reservoir solutions supplemented with 20–25% glycerol. All data
obtained in this project were collected at 100 K on SLS beamline PX3 (Villigen,
Switzerland).
Structure determination, model building and refinement. The crystallographic
data were processed and scaled using XDS66 and Aimless67. Structures of AncINS
and AncFT were solved by molecular replacement using AncHLD-RLuc (PDB ID
6G7514) as a search model with the help of Phaser68 as implemented in the Phenix
package69. The structure of RLuc8-W121F/E144Q was solved by molecular
replacement with Phenix2 using the RLuc8 structure (PDB ID 2PSD) as a search
model. Multiple cycles of automated refinement were performed in the phenix.
refine programme69 and manual model building was performed in Coot70. The
final models were validated using tools provided in Coot70 and Molprobity71.
Ramachandran favoured 95.3%, 95.9% and 96.6%, Ramachandran allowed 4.4%,
3.8% and 3.4%, Ramachandran outliers 0.3%, 0.3% and 0% for AncINS, AncFT and
RLuc8-W121F/E144Q, respectively. Structural data were graphically visualized
with PyMol Molecular Graphics System, version 1.8 (Schrödinger, LLC). Atomic
coordinates and structure factors for AncINS, AncFT and RLuc8-W121F/E144Q
were deposited in the Protein Data Bank under the codes 6S6E, 6S97, and 6YN2,
respectively.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Atomic coordinates and experimental data have been deposited in the Protein Data Bank
(www.wwpdb.org). They are publicly available for accession codes 6S6E and 6S97; 6YN2
will be released upon article publication. The validation reports are provided in
Supplementary Notes 7, 8 and 9. The primary data from microfluidics are available in
figshare with the identifier https://doi.org/10.6084/m9.figshare.14453700.v1. Source data
are provided with this paper.
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